Concordance in temporally distinct blood and sputum inflammatory phenotypic measures in severe asthma

C. Barber (Southampton, United Kingdom), A. Azim (Southampton, United Kingdom), J. Ward (Southampton, United Kingdom), L. Lau (Southampton, United Kingdom), K. Tariq (Southampton, United Kingdom), P. Dennison (Southampton, United Kingdom), B. Green (Portsmouth, United Kingdom), T. Hinks (Oxford, United Kingdom), K. Staples (Southampton, United Kingdom), P. Howarth (Southampton, United Kingdom)

Source: International Congress 2019 – Clinical implications of asthma management
Session: Clinical implications of asthma management
Session type: Poster Discussion
Number: 5039
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Barber (Southampton, United Kingdom), A. Azim (Southampton, United Kingdom), J. Ward (Southampton, United Kingdom), L. Lau (Southampton, United Kingdom), K. Tariq (Southampton, United Kingdom), P. Dennison (Southampton, United Kingdom), B. Green (Portsmouth, United Kingdom), T. Hinks (Oxford, United Kingdom), K. Staples (Southampton, United Kingdom), P. Howarth (Southampton, United Kingdom). Concordance in temporally distinct blood and sputum inflammatory phenotypic measures in severe asthma. 5039

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Functional, clinical evolution and cellular inflammatory pattern in induced sputum in patients with difficult-to-control asthma
Source: Annual Congress 2011 - Update on monitoring airway diseases
Year: 2011


Biomarkers to identify sputum eosinophilia in different adult asthma phenotypes
Source: Eur Respir J 2015; 46: 688-696
Year: 2015



Associations between blood and sputum eosinophils and clinical features of mild-to-moderate COPD
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019

Discriminating phenotypes of severe eosinophilic asthma using gene profiling in sputum
Source: International Congress 2018 – Does asthma phenotyping improve treatment?
Year: 2018



Overlapping biologic exacerbation clusters in asthma and chronic obstructive pulmonary disease have distinct sputum mediator and microbiome profiles
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018




Cellular inflammatory pattern in induced sputum among patients with stable moderate or severe asthma
Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases
Year: 2010


Distribution of the cellular inflammatory pattern in induced sputum in an eosinophilic severe asthma population.
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019


Sputum neutrophilic markers in asthma of varying severity and COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 550s
Year: 2003

The clinical, spirometric and cytological profiles of exacerbations in poorly controlled severe persistent asthmatics
Source: Annual Congress 2007 - Towards controlling severe asthma
Year: 2007




Correlation between sputum and blood eosinophils in asthmatic and COPD patients with comorbidities.
Source: International Congress 2018 – Airway disease: recent discoveries
Year: 2018

Blood inflammatory patterns in different respiratory phenotypes from the general population
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010

Airway eosinophilia is not related to clinical and functional findings in a large group of severe refractory asthmatics
Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers vs induced sputum
Year: 2006


Biochemical parameters of sputum and their correlation with inflammation blood markers in AECOPD patients
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010


Evolution of cellular inflammatory pattern in induced sputum in patients with mild-moderate asthma for five years
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011


Longitudinal variability of pulmonary function and sputum eosinophilia in severe refractory asthmatics
Source: Eur Respir J 2003; 22: Suppl. 45, 479s
Year: 2003

Sputum analysis reveals eosinophilic inflammation in difficult-to-control asthma patients with low blood eosinophils and FENO.
Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma
Year: 2020


Associations of blood cytokines and eosinophils in severe asthma
Source: International Congress 2017 – Clinical points to ponder in asthma
Year: 2017


The use of sputum differential cell counts and soluble phase measurements to assess airway inflammation in children with asthma exacerbation
Source: Eur Respir J 2002; 20: Suppl. 38, 142s
Year: 2002

Associations of COPD severity and severity of exacerbation with sputum microbiologic profile and long-term survival
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008


Serial blood eosinophils and clinical characteristics in COPD patients without a history of asthma or atopy
Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses
Year: 2019